Search Results - "O’Neill, Anne M."

Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188) by DAVIDSON, Nancy E, O'NEILL, Anne M, VUKOV, Allen M, OSBORNE, C. Kent, MARTINO, Silvana, WHITE, Douglas R, ABELOFF, Martin D

“…Chemotherapy, tamoxifen, and ovarian ablation/suppression (OA/OS) are effective adjuvant approaches for premenopausal, steroid hormone receptor-positive breast…”
Get full text

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off by Upshaw, Jenica N., Ruthazer, Robin, Miller, Kathy D., Parsons, Susan K., Erban, John K., O’Neill, Anne M., Demissei, Biniyam, Sledge, George, Wagner, Lynne, Ky, Bonnie, Kent, David M.

“…Anthracycline agents can cause cardiotoxicity. We used multivariable risk prediction models to identify a subset of patients with breast cancer at high risk of…”
Get full text

Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805 by Bottinor, Wendy J, Flamand, Yael, Haas, Naomi B, ONeill, Anne M, DiPaola, Robert S, Subramanian, Pearl, Cella, David, Hundley, W Gregory, Wagner, Lynne I, Salsman, John M, Ky, Bonnie

“…Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among adolescents and young adults (AYAs) diagnosed with cancer. The aim of this…”
Get more information

A Pilot Phase II Trial of Valspodar Modulation of Multidrug Resistance to Paclitaxel in the Treatment of Metastatic Carcinoma of the Breast (E1195): A Trial of the Eastern Cooperative Oncology Group by Carlson, Robert W., O'Neill, Anne M., Goldstein, Lori J., Sikic, Branimir I., Abramson, Neil, Stewart, James A., Davidson, Nancy E., Wood, William C.

“…Background: To assess the activity and toxicity of valspodar (PSC-833) in combination with paclitaxel in women with anthracycline refractory, metastatic breast…”
Get full text

Social determinants of health, genetic ancestry, and mortality in ECOG-ACRIN E5103 by Obeng-Gyasi, Samilia, O'Neill, Anne M., Miller, Kathy, Schneider, Bryan P., Partridge, Ann H., Timsina, Lava R, Sledge, George W., Wagner, Lynne I., Carlos, Ruth

“…Abstract only 6527 Background: Social determinants of health (SDH) and genetic ancestry have been independently implicated in breast cancer presentation,…”
Get full text

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial by Sparano, Joseph A., O'Neill, Anne M., Graham, Noah, Northfelt, Donald W., Dang, Chau T., Wolff, Antonio C., Sledge, George W., Miller, Kathy

“…Abstract only 520 Background: Systemic inflammation may contribute to cancer progression (PMC2803035), including recurrence of early breast cancer…”
Get full text

Patient-reported outcomes (PROs) from a phase II trial of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal and/or pulmonary involvement by Pai, Sara I., Franco, Ramon, Muniappan, Ashok, Friedman, Aaron D, Park, Jong Chul, Campbell, Nicholas Paul, Krantz, Seth B., Song, Phillip C, Nocon, Cheryl, Carroll, Thomas L, Faquin, William C, Shin, Kee-Young, O'Neill, Anne M., Wirth, Lori J.

“…Abstract only 6080 Background: Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 & 11. RRP proliferates in the…”
Get full text

Neoadjuvant and adjuvant nivolumab and lirilumab in patients with recurrent, resectable squamous cell carcinoma of the head and neck by Hanna, Glenn J., O'Neill, Anne M., Jo, Vickie Y., Wong, Kristine, Lizotte, Patrick H., Annino, Donald J., Goguen, Laura A., Kass, Jason I., Rettig, Eleni M., Sethi, Rosh K.V., Lorch, Jochen H., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Everett, Peter C., Desai, Anupam M., Paweletz, Cloud P., Egloff, Ann Marie, Uppaluri, Ravindra, Haddad, Robert I.

“…Abstract only 6053 Background: Locoregional recurrence (LRR) is a major cause of death for patients (pts) with squamous cell carcinoma of the head and neck…”
Get full text

Urgent hypertension as a biomarker for bevacizumab in the curative setting by Kassem, Nawal, Shen, Fei, Jiang, Guanglong, Gardner, Laura, Philips, Santosh, O'Neill, Anne M., Miller, Kathy D., Suter, Thomas, Cameron, David A., Sledge, George W., Schneider, Bryan Paul

“…Abstract only…”
Get full text

A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement by Pai, Sara I., Friedman, Aaron D, Franco, Ramon, Muniappan, Ashok, Park, Jong Chul, Campbell, Nicholas Paul, Krantz, Seth B., Song, Phillip C, Bove, Michiel, Carroll, Thomas L, Faquin, William C, O'Neill, Anne M., Wirth, Lori J.

“…Abstract only 2502 Background: Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 & 11. RRP proliferates in the…”
Get full text

Symptom burden and employment status in breast cancer (BC) survivors by Luis, Ines Maria Vaz Duarte, O'Neill, Anne M., Sepucha, Karen, Miller, Kathy D., Dang, Chau T., Northfelt, Donald W., Winer, Eric P., Sledge, George W., Schneider, Bryan P., Partridge, Ann

“…Abstract only…”
Get full text

A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN) by Lorch, Jochen H., Tishler, Roy B., Chau, Nicole Grace, Hanna, Glenn J., Rabinowits, Guilherme, Schoenfeld, Jonathan Daniel, Margalit, Danielle Nina, O'Neill, Anne M., Annino, Donald, Goguen, Laura A, Uppaluri, Ravi, Harris, Ethan James, Kacew, Alec, Huang, Julian, Ma, Laura, Mchugh, Patricia, Haddad, Robert I.

“…Abstract only…”
Get full text

Association of Charcot-Marie-Tooth gene, SBF2 , with taxane-induced peripheral neuropathy in African Americans by Schneider, Bryan P., Lai, Dongbing, Shen, Fei, Jiang, Guanglong, Radovich, Milan, Li, Lang, Gardner, Laura, Miller, Kathy D., O'Neill, Anne M., Sparano, Joseph A., Xue, Gloria, Foroud, Tatiana, Sledge, George W.

“…Abstract only…”
Get full text

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial by Haddad, Robert, Dr, O'Neill, Anne, MS, Rabinowits, Guilherme, MD, Tishler, Roy, MD, Khuri, Fadlo, Prof, Adkins, Douglas, MD, Clark, Joseph, Prof, Sarlis, Nicholas, MD, Lorch, Jochen, MD, Beitler, Jonathan J, Prof, Limaye, Sewanti, MD, Riley, Sarah, MD, Posner, Marshall, Prof

“…Summary Background The relative efficacy of the addition of induction chemotherapy to chemoradiotherapy compared with chemoradiotherapy alone for patients with…”
Get full text

A phase II prospective trial correlating progression-free survival (PFS) with CYP2D6 activity in patients with metastatic breast cancer treated with tamoxifen: ECOG-ACRIN E3108 by Stearns, Vered, O'Neill, Anne M., Schneider, Bryan P., Flockhart, David A., Skaar, Todd C., Liu, Minetta C., Lohrisch, Caroline A., Goetz, Matthew P., Vallejos Sologuren, Carlos, Sparano, Joseph A., Villa, Diego, Silverman, Paula, Cheema, Puneet S., Moore, Dennis Frederic, Sledge, George W.

“…Abstract only…”
Get full text

Genome wide association study for anthracycline-induced congestive heart failure by Gardner, Laura, Shen, Fei, Radovich, Milan, Li, Lang, Miller, Kathy, Jiang, Guanglong, Lai, Dongbing, O'Neill, Anne M., Sparano, Joseph A., Davidson, Nancy E., Cameron, David A., Gradus-Pizlo, Irmina, Mastouri, Ronald, Suter, Thomas M., Foroud, Tatiana, Sledge, George W., Schneider, Bryan P.

“…Abstract only…”
Get full text

Biomarker prediction of chemotherapy-related amenorrhea by Ruddy, Kathryn Jean, O'Neill, Anne M., Miller, Kathy, Schneider, Bryan P., Baker, Emily, Sparano, Joseph A., Dang, Chau T., Northfelt, Donald W., Sledge, George W.

“…Abstract only 9508 Background: Chemotherapy-related amenorrhea (CRA) is associated with infertility and may impact treatment decision-making. We investigated…”
Get full text

Does unblinding of treatment assignment impact participant perceptions in clinical trials? by Partridge, Ann H., Sepucha, Karen, O'Neill, Anne M., Miller, Kathy, Motley, Christine, Swaby, Ramona F., Schneider, Bryan P., Dang, Chau T., Northfelt, Donald W., Sledge, George W.

“…Abstract only 6025 Background: Blinding patients to treatment regimen is an important component of high quality randomized clinical trials although concern…”
Get full text

miRNA analysis between malignant and benign tissue and circulating exosomes (CE) in patients (pts) with tongue squamous cell carcinoma by Rabinowits, Guilherme, Flores, Ludmila, O'Neill, Anne M., Stevenson, Kristen, Ghobrial, Irene M., Vergara, Victoria, Jo, Vickie Y, Verselis, Sigitas Jonas, Chau, Nicole Grace, Lorch, Jochen H., Haddad, Robert I.

“…Abstract only 6088 Background: The identification of a specific miRNA pattern in HNSCC is challenging given the heterogeneity of this disease and different…”
Get full text

Long-term symptom burden and orodental health of oropharyngeal cancer (OPC) survivors following treatment with chemoradiotherapy (CRT) or sequential therapy (ST) by Limaye, Sewanti Atul, Haddad, Robert I., Partridge, Ann, O'Neill, Anne M., Radossi, Andrea, Shreenivas, Aditya V., Lorente, David, Hanna, Glenn J., Sonis, Stephen T., Shulman, Lawrence N., Posner, Marshall R., Lorch, Jochen H.

“…Abstract only 9530 Background: OPC treatment is associated with significant long-term toxicity. Very little is known about the long-term symptom burden and…”
Get full text